BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 19926611)

  • 21. Circadian disruption in experimental cancer processes.
    Filipski E; Lévi F
    Integr Cancer Ther; 2009 Dec; 8(4):298-302. PubMed ID: 20042408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circadian time-dependent tumor suppressor function of period genes.
    Yang X; Wood PA; Ansell C; Hrushesky WJ
    Integr Cancer Ther; 2009 Dec; 8(4):309-16. PubMed ID: 19926612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies.
    Taniguchi H; Fernández AF; Setién F; Ropero S; Ballestar E; Villanueva A; Yamamoto H; Imai K; Shinomura Y; Esteller M
    Cancer Res; 2009 Nov; 69(21):8447-54. PubMed ID: 19861541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence supporting a circadian control of natural killer cell function.
    Arjona A; Sarkar DK
    Brain Behav Immun; 2006 Sep; 20(5):469-76. PubMed ID: 16309885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronotherapy and the molecular clock: Clinical implications in oncology.
    Innominato PF; Lévi FA; Bjarnason GA
    Adv Drug Deliv Rev; 2010 Jul; 62(9-10):979-1001. PubMed ID: 20600409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetics of the sleep-wake cycle and its disorders.
    Hamet P; Tremblay J
    Metabolism; 2006 Oct; 55(10 Suppl 2):S7-12. PubMed ID: 16979429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Jet lag: therapeutic use of melatonin and possible application of melatonin analogs.
    Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
    Travel Med Infect Dis; 2008; 6(1-2):17-28. PubMed ID: 18342269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells.
    Gery S; Komatsu N; Baldjyan L; Yu A; Koo D; Koeffler HP
    Mol Cell; 2006 May; 22(3):375-82. PubMed ID: 16678109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shedding light on circadian clock resetting by dark exposure: differential effects between diurnal and nocturnal rodents.
    Mendoza J; Revel FG; Pévet P; Challet E
    Eur J Neurosci; 2007 May; 25(10):3080-90. PubMed ID: 17561821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diurnal rhythmicity of the canonical clock genes Per1, Per2 and Bmal1 in the rat adrenal gland is unaltered after hypophysectomy.
    Fahrenkrug J; Hannibal J; Georg B
    J Neuroendocrinol; 2008 Mar; 20(3):323-9. PubMed ID: 18208549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Working under daylight intensity lamp: an occupational risk for developing circadian rhythm sleep disorder?
    Doljansky JT; Kannety H; Dagan Y
    Chronobiol Int; 2005; 22(3):597-605. PubMed ID: 16076658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insight into the circadian clock within rat colonic epithelial cells.
    Sládek M; Rybová M; Jindráková Z; Zemanová Z; Polidarová L; Mrnka L; O'Neill J; Pácha J; Sumová A
    Gastroenterology; 2007 Oct; 133(4):1240-9. PubMed ID: 17675004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of exogenous melatonin and circadian synchronization on tumor progression in melanoma-bearing C57BL6 mice.
    Otálora BB; Madrid JA; Alvarez N; Vicente V; Rol MA
    J Pineal Res; 2008 Apr; 44(3):307-15. PubMed ID: 18339126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circadian rhythm sleep disorders in the blind and their treatment with melatonin.
    Skene DJ; Arendt J
    Sleep Med; 2007 Sep; 8(6):651-5. PubMed ID: 17420154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Advanced sleep phase syndrome (ASPS) and delayed sleep phase syndrome (DSPS)].
    Kajimura N; Takahashi K
    Nihon Rinsho; 1998 Feb; 56(2):404-9. PubMed ID: 9503842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer.
    Rich T; Innominato PF; Boerner J; Mormont MC; Iacobelli S; Baron B; Jasmin C; Lévi F
    Clin Cancer Res; 2005 Mar; 11(5):1757-64. PubMed ID: 15755997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Making circadian cancer therapy practical.
    Block KI; Block PB; Fox SR; Birris JS; Feng AY; de la Torre M; Nathan D; Tothy P; Maki AK; Gyllenhaal C
    Integr Cancer Ther; 2009 Dec; 8(4):371-86. PubMed ID: 20042412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronotherapeutics: the relevance of timing in cancer therapy.
    Lévi F
    Cancer Causes Control; 2006 May; 17(4):611-21. PubMed ID: 16596317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Light exposure during daytime modulates expression of Per1 and Per2 clock genes in the suprachiasmatic nuclei of mice.
    Challet E; Poirel VJ; Malan A; Pévet P
    J Neurosci Res; 2003 Jun; 72(5):629-37. PubMed ID: 12749028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of light and food schedules on liver and tumor molecular clocks in mice.
    Filipski E; Innominato PF; Wu M; Li XM; Iacobelli S; Xian LJ; Lévi F
    J Natl Cancer Inst; 2005 Apr; 97(7):507-17. PubMed ID: 15812076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.